Company: BDRX
Filing Date: 2025-01-28
Form Type: 424B3
Source: 0001214659-25-001409
Chunk: 113

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-28
Form: 424B3
Chunk 113
---
 predict whether the net proceeds invested will yield a favorable return.

In accordance with our obligations
under the Purchase Agreement and the Registration Rights Agreement, dated as of January 17, 2025, between us and the Selling Shareholder,
or the Registration Rights Agreement, pursuant to which we agreed to provide the Selling Shareholder with customary registration rights
related to the shares issued under the Purchase Agreement, we have filed a registration statement of which this prospectus forms a part
in order to register the resale of up to: (i) 35,000,000 Purchase Shares that we may elect, in our sole discretion, to issue and sell
to the Selling Shareholder, from time to time after the Commencement Date upon the terms and subject to the conditions and limitations
of the Purchase Agreement (assuming the shares are sold at a price of $1.00 per share); and (ii) 875,000 Commitment Shares that may be
issued to the Selling Shareholder in certain circumstances in connection with related issuances and sales of Purchase Shares to release
the Company of its liability to pay the Commitment Fee as consideration for the Selling Shareholder’s execution and delivery of
the Purchase Agreement (assuming the shares are issued at a price of $1.00 per share).

The Selling Shareholder is
not obligated to buy any Depositary Shares under the Purchase Agreement if such shares, when aggregated with all other securities then
beneficially owned by the Selling Shareholder and its respective affiliates (as calculated pursuant to Section 13(d) of the Exchange Act
and Rule 13d-3 promulgated thereunder), would result in the Selling Shareholder beneficially owning Ordinary Shares in excess of the Beneficial
Ownership Limitation. Our inability to access a portion or the full amount available under the Purchase Agreement, in the absence of any
other financing sources, could have a material adverse effect on our business or results of operation.

The Purchase Agreement and
Registration Rights Agreement contain customary registration rights, representations, warranties, conditions and indemnification obligations
by each party. The representations, warranties and covenants contained in such agreements were made only for purposes of such agreements
and as of specific dates, were solely for the benefit of the parties to such agreements and are subject to certain important limitations.

Purchase Agreement

Pursuant to the Purchase Agreement,
the Selling Shareholder shall, subject to the restrictions and satisfaction of the conditions in the Purchase Agreement, purchase from
us up to $35.0 million of Depositary